DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

INSMED, INC. (NASDAQ: INSM)

20.50 1.03 (5.29%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INSM $20.50 5.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $19.48
Previous Close $19.47
Daily Range $19.48 - $20.74
52-Week Range $11.25 - $22.59
Market Cap $1.0B
P/E Ratio -10.58
Dividend (Yield) $0.00 (0.0%)
Volume 528,779
Average Daily Volume 564,498
Current FY EPS -$2.06

Sector

Healthcare

Industry

Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website: http://www.insmed.com/

News & Commentary Rss Feed

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Should You Buy Insmed Incorporated Ahead of Earnings? - Tale of the Tape

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

5 Red-Hot Biotech Stocks to Buy

Insmed Incorporated (INSM) in Focus: Stock Up 10.9% - Tale of the Tape

Markets Rise; Macy's Lowers Comparable Sales Outlook

Markets Rise; Macy's Lowers Comparable Sales Outlook

Benzinga's Volume Movers

See More INSM News...

INSM's Top Competitors

INSM $20.50 (5.29%)
Current stock: INSM
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB